Exchange: NASDAQ·Updated 07:51 PM EDT
News
all
press releases
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) delivered earnings and revenue surprises of -400.00% and +12.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global (NASDAQ:OGI)read more...
Benzinga
Organigram Reports Record Third Quarter Fiscal 2026 Results
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (Sanity or Sanity Group), today announced its results for the third quarter ended June...
Business Wire
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -13.33% and +3.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of +100.00% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2
Evolus (EOLS) delivered earnings and revenue surprises of +100.00% and +2.59%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (Sanity), announced today it will report earnings results for its third quarter ended June...
Business Wire
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the Company or Organigram), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (Sanity), today provided a business update highlighting initial operating performance from...
Business Wire
OrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript
read more...
Benzinga

Advertisement|Remove ads.